QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 210 filers reported holding QIAGEN NV in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exane Asset Management | 642,752 | $14,260,214,000 | 5.53% |
| Tikvah Management LLC | 369,425 | $8,057,000 | 4.72% |
| Hardman Johnston Global Advisors LLC | 3,797,024 | $82,813,000 | 4.22% |
| HealthCor Management, L.P. | 2,500,000 | $54,525,000 | 2.97% |
| Opus Point Partners Management, LLC | 105,751 | $2,306,000 | 2.23% |
| CRAMER ROSENTHAL MCGLYNN LLC | 4,018,074 | $87,634,000 | 1.41% |
| Douglas Lane & Associates, LLC | 1,942,678 | $42,370,000 | 1.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,167,768 | $47,279,000 | 1.17% |
| MANNING & NAPIER ADVISORS LLC | 6,111,364 | $133,287,000 | 0.81% |
| PRIMECAP MANAGEMENT CO/CA/ | 20,128,325 | $438,999,000 | 0.47% |